XRAY FINANCIAL STATEMENTS

Dentsply Sirona Inc — balance sheet, income statement and cash flow trends

XRAYDentsply Sirona Inc

🇺🇸 USA · NASDAQ · Healthcare · Medical Instruments & Supplies

Value it Duel

Income Statement

Quarterly progression — trailing-twelve-month values

RevenueNet Income

Profit Funnel

Q1 2026 · TTM

Percentages are relative to revenue.

Key Figures

YoY change

Revenue3.7 B $-1.0%

Gross Profit1.8 B $-6.1%

Operating Income216 M $—

EBITDA-127 M $—

Net Income-628 M $—

Peer Comparison· Medical Instruments & Supplies

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
XRAY	-1.0%	48.9%	-3.5%	-17.1%
ANN	11.4%	41.9%	15.2%	6.7%
FPH	4.8%	64.2%	34.9%	20.0%
RMD	10.5%	61.2%	39.1%	27.4%
CTEC	6.8%	55.8%	25.3%	7.2%
EL	7.5%	60.6%	23.0%	8.1%
Industry median	6.4%	53.7%	13.8%	3.9%

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
XRAY	-1.0%	48.9%	-3.5%	-17.1%
LMAT	13.3%	72.4%	37.6%	24.3%
PLSE	-69.9%	-91.1%	-9,866.7%	-9,929.0%
ATRC	15.0%	75.5%	4.5%	-0.8%
WRBY	12.0%	53.4%	6.1%	0.2%
STAA	4.0%	76.4%	-1.4%	-7.2%
Industry median	6.4%	53.7%	13.8%	3.9%

Balance Sheet

Quarterly period-end values

Total AssetsTotal LiabilitiesEquity

Capital Structure

Q1 2026

Equity1.3 B $25%
Current Liabilities1.2 B $23%
Long-term Liabilities2.7 B $52%

Key Figures

YoY change

Total Assets5.2 B $-13.6%

Total Liabilities3.9 B $-3.2%

Total Equity1.3 B $-34.4%

Cash & ST Investments190 M $-52.3%

Total Debt2.3 B $-3.8%

Net Debt2.1 B $+5.7%

Peer Comparison· Medical Instruments & Supplies

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
XRAY	1.53	176.9%	-16.86	25.2%
ANN	2.36	46.2%	2.10	59.3%
FPH	2.31	6.9%	-0.39	74.1%
RMD	3.01	13.0%	-0.38	73.9%
CTEC	1.53	100.0%	2.33	40.1%
EL	0.99	37.0%	1.66	60.9%
Industry median	2.40	34.8%	1.44	62.7%

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
XRAY	1.53	176.9%	-16.86	25.2%
LMAT	14.32	46.7%	-1.84	64.6%
PLSE	7.26	10.8%	0.83	81.2%
ATRC	4.29	15.2%	-2.88	76.4%
WRBY	2.33	63.2%	-0.94	51.0%
STAA	5.12	10.6%	30.83	78.1%
Industry median	2.40	34.8%	1.44	62.7%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values

Operating Cash FlowCapital ExpendituresFree Cash Flow

Cash Flow Bridge

Q1 2026 · TTM

Key Figures

YoY change

Operating Cash Flow268 M $-39.5%

Capital Expenditures164 M $-0.6%

Free Cash Flow104 M $-62.6%

Dividends Paid-128 M $-199.2%

Peer Comparison· Medical Instruments & Supplies

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
XRAY	7.3%	2.8%	4.5%	-42.7%
ANN	11.7%	8.3%	3.4%	173.5%
FPH	28.4%	21.0%	7.4%	141.7%
RMD	34.2%	31.7%	2.5%	124.8%
CTEC	19.1%	14.1%	4.9%	265.8%
EL	18.6%	13.2%	5.4%	228.6%
Industry median	13.8%	8.6%	3.8%	128.3%

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
XRAY	7.3%	2.8%	4.5%	-42.7%
LMAT	34.1%	30.9%	3.2%	139.9%
PLSE	-7,349.7%	-7,390.0%	40.3%	74.0%
ATRC	11.7%	9.7%	3.2%	-1,401.3%
WRBY	11.9%	4.4%	7.5%	7,870.6%
STAA	-17.3%	-18.9%	1.7%	238.7%
Industry median	13.8%	8.6%	3.8%	128.3%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on XRAY

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.